日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma

自动化淋巴结和结外侵犯评估可改善口咽癌的风险分层

Ye, Zezhong; Mojahed-Yazdi, Reza; Zapaishchykova, Anna; Tak, Divyanshu; Mahootiha, Maryam; Pardo, Juan Carlos Climent; Zielke, John; Zha, Yining; Guthier, Christian; Tishler, Roy B; Margalit, Danielle N; Schoenfeld, Jonathan D; Haddad, Robert I; Uppaluri, Ravindra; Haibe-Kains, Benjamin; Fuller, Clifton D; Naser, Mohamed; Burtness, Barbara A; Aerts, Hugo J W L; Hoebers, Frank; Kann, Benjamin H

NN-01-195, a novel conjugate of HSP90 and AURKA inhibitors, effectively targets solid tumors.

NN-01-195 是一种新型的 HSP90 和 AURKA 抑制剂偶联物,可有效靶向实体瘤。

Nguyen Theodore T, Nandwana Nitesh K, Srikanth Yellamelli V V, Bagnyukova Tetyana, Chkalo Oleksandra, Cai Kathy Q, Lamperelli Julia, Pirestani Shabnam, Mehra Manish Kumar, Burtness Barbara A, Borghaei Hossein, Akunuri Ravikumar, Cassel Joel, Lu Lily, Salvino Joseph M, Golemis Erica A

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

一项针对局部晚期头颈部鳞状细胞癌患者的 1 期研究,评估 berzosertib (M6620, VX-970) 与顺铂和放射治疗的疗效 (ETCTN 9950)

Bhatia, Aarti; Chen, Zhengjia; Zhang, Yuji; Bruce, Justine Yang; Arnold, Susanne; Kaur, Varinder; Riess, Jonathan W; Fenton, Moon; Burtness, Barbara; Saba, Nabil F; Tara, Harold; Steuer, Conor E; Shin, Dong M; Wasp, Garrett; Davis, Thomas H; Patel, Malini; Schmitz, John C; Bhateja, Priyanka; Diavolitsis, Virginia; Zandberg, Dan P; Mitchell, Darrion L; Kiesel, Brian F; Kunos, Charles; Gore, Steven D; Carducci, Michael; Beumer, Jan H; Owonikoko, Taofeek K

Re-defining standards of care in resectable head and neck squamous cell carcinoma-lessons from KEYNOTE-689 and NIVOPOSTOP

重新定义可切除头颈部鳞状细胞癌的治疗标准——KEYNOTE-689 和 NIVOPOSTOP 会议的经验教训

Mehra, Saral; Yom, Sue S; Burtness, Barbara

STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma

STING 可预测局部晚期头颈部鳞状细胞癌的复发模式

MacNeil, Tyler; Hayman, Thomas J; Li, Shengguo; Moutafi, Myrto; Martinez-Morilla, Sandra; Vathiotis, Ioannis A; Hu, Rong; Harari, Paul M; Burtness, Barbara; Liu, Hao; Kimple, Randall J; Rimm, David L; Contessa, Joseph N

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC

JADE:一项针对局部晚期不可切除头颈部鳞状细胞癌患者的化疗放疗后序贯使用多斯他利单抗的3期研究

Siu, Lillian L; Burtness, Barbara; Harrington, Kevin; Psyrri, Amanda; Saba, Nabil F; Tahara, Makoto; Carlson, Gary; Dhar, Arindam; Grimshaw, Matthew; Hua, Lei; Iadevaia, Riham; Theti, Davinder; Vlahovic, Gordana; Machiels, Jean-Pascal

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer

中危头颈癌术后放疗±西妥昔单抗治疗

Machtay, Mitchell; Torres-Saavedra, Pedro A; Thorstad, Wade; Nguyen-Tân, Phuc Felix; Siu, Lillian L; Holsinger, F Christopher; El-Naggar, Adel; Chung, Christine; Cmelak, Anthony; Burtness, Barbara; Bednarz, Greg; Quon, Harry; Breen, Stephen L; Gwede, Clement K; Dicker, Adam P; Yao, Min; Jordan, Richard C; Dorth, Jennifer; Lee, Nancy; Chan, Jason W; Dunlap, Neal; Bar-Ad, Voichita; Stokes, William A; Chakravarti, Arnab; Sher, David; Rao, Shyam; Harris, Jonathan; Yom, Sue S; Le, Quynh-Thu

Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study

在无法切除的局部晚期头颈部鳞状细胞癌中,Xevinapant 或安慰剂联合铂类化疗放疗的疗效比较(TrilynX):一项随机、III 期研究

Bourhis, Jean; Licitra, Lisa F; Burtness, Barbara; Psyrri, Amanda; Haddad, Robert; Harrington, Kevin; Cohen, Ezra E W; Tao, Yungan; Tiscoski, Katsuki Arima; Matitashvili, Amiran; Tahara, Makoto; Sukari, Ammar; Rutkowski, Tomasz; Salas, Sebastien; Nauwelaerts, Heidi; Scheerlinck, Rudi; Ha, Ngoc-Thuy; Schroeder, Andreas; Rodriguez-Gutierrez, Almudena; Schoenfeld, Jonathan D

Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer

E3311研究的长期随访:一项ECOG-ACRIN癌症研究组II期临床试验,旨在评估经口手术和基于风险的辅助治疗在人乳头瘤病毒(HPV)感染引起的口咽癌中的疗效

Burtness, Barbara; Flamand, Yael; Quon, Harry; Weinstein, Gregory S; Mehra, Ranee; Garcia, Joaquin J; Kim, Seungwon; O'Malley, Bert W Jr; Ozer, Enver; Ikpeazu, Chukwuemeka; Koch, Wayne M; Gross, Neil D; Bell, R Bryan; Patel, Mihir; Lango, Miriam N; Morris, Luc G; Smith, Russell; Karakla, Daniel; Richmon, Jeremy D; Holsinger, Floyd C; Ferris, Robert L

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163

新辅助化疗联合手术与器官保留手术治疗T3和T4a期鼻及鼻窦鳞状细胞癌的比较:ECOG-ACRIN EA3163

Saba, Nabil F; Flamand, Yael; Lin, Derrick T; Chung, Christine H; McDonald, Mark W; Flampouri, Styliani; Khan, Saad A; Snyderman, Carl H; Hanna, Ehab Y; El-Sayed, Ivan H; Solares, Clementino A; Le, Christopher H; Ghaly, Maged; Hwang, Peter H; Shin, Dong M; Axelrod, Rita S; Ikpeazu, Chukwuemeka V; Adkins, Douglas R; Duan, Fenghai; Cohen, Marc; Samuels, Michael A; Swiecicki, Paul L; Subramaniam, Rathan M; Chakravarthy, A Bapsi; Burtness, Barbara A